Brandon Arnieri

711 total citations · 1 hit paper
10 papers, 498 citations indexed

About

Brandon Arnieri is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Brandon Arnieri has authored 10 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Brandon Arnieri's work include Lung Cancer Treatments and Mutations (4 papers), Cancer Genomics and Diagnostics (3 papers) and Machine Learning in Healthcare (2 papers). Brandon Arnieri is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Cancer Genomics and Diagnostics (3 papers) and Machine Learning in Healthcare (2 papers). Brandon Arnieri collaborates with scholars based in United States, Switzerland and France. Brandon Arnieri's co-authors include William B. Capra, Gillis Carrigan, Michael D. Taylor, Samuel Whipple, Michael W. Lu, Ryan Copping, Melisa Tucker, Sandra D. Griffith, Aracelis Z. Torres and Shemra Rizzo and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Blood.

In The Last Decade

Brandon Arnieri

10 papers receiving 487 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evaluating eligibility criteria of oncology trials using real-world data and AI

2021 184 citations Ruishan Liu, Shemra Rizzo et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brandon Arnieri United States	6	175	140	117	112	93	10	498
Navdeep Pal United States	11	189 1.1×	127 0.9×	55 0.5×	63 0.6×	90 1.0×	26	689
Samuel Whipple United States	5	56 0.3×	58 0.4×	100 0.9×	90 0.8×	53 0.6×	9	312
Timothy A. Lin United States	12	131 0.7×	118 0.8×	60 0.5×	130 1.2×	80 0.9×	60	561
Melissa D. Curtis United States	6	258 1.5×	217 1.6×	49 0.4×	68 0.6×	78 0.8×	8	427
Aracelis Z. Torres United States	14	510 2.9×	388 2.8×	87 0.7×	108 1.0×	162 1.7×	34	826
Ryan Copping United States	7	43 0.2×	47 0.3×	104 0.9×	95 0.8×	63 0.7×	9	355
Ellie Siden Canada	10	81 0.5×	64 0.5×	110 0.9×	85 0.8×	110 1.2×	15	527
Travis Osterman United States	11	127 0.7×	59 0.4×	18 0.2×	54 0.5×	64 0.7×	33	504
Melisa Tucker United States	9	357 2.0×	301 2.1×	70 0.6×	86 0.8×	123 1.3×	13	566
Eduard J. Gamito United States	14	177 1.0×	364 2.6×	52 0.4×	49 0.4×	70 0.8×	27	717

Countries citing papers authored by Brandon Arnieri

Since Specialization

Citations

This map shows the geographic impact of Brandon Arnieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandon Arnieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandon Arnieri more than expected).

Fields of papers citing papers by Brandon Arnieri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brandon Arnieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandon Arnieri. The network helps show where Brandon Arnieri may publish in the future.

Co-authorship network of co-authors of Brandon Arnieri

This figure shows the co-authorship network connecting the top 25 collaborators of Brandon Arnieri. A scholar is included among the top collaborators of Brandon Arnieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brandon Arnieri. Brandon Arnieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Liu, Ruishan, Shemra Rizzo, Samuel Whipple, et al.. (2021). Evaluating eligibility criteria of oncology trials using real-world data and AI. Nature. 592(7855). 629–633. 184 indexed citations breakdown →

Luhn, Patricia, Deborah Kuk, Gillis Carrigan, et al.. (2019). Validation of diagnosis codes to identify side of colon in an electronic health record registry. BMC Medical Research Methodology. 19(1). 177–177. 21 indexed citations

Carrigan, Gillis, Samuel Whipple, William B. Capra, et al.. (2019). Using Electronic Health Records to Derive Control Arms for Early Phase Single‐Arm Lung Cancer Trials: Proof‐of‐Concept in Randomized Controlled Trials. Clinical Pharmacology & Therapeutics. 107(2). 369–377. 72 indexed citations

Carrigan, Gillis, Samuel Whipple, Michael D. Taylor, et al.. (2019). An evaluation of the impact of missing deaths on overall survival analyses of advanced non–small cell lung cancer patients conducted in an electronic health records database. Pharmacoepidemiology and Drug Safety. 28(5). 572–581. 43 indexed citations

Barlési, Fabrice, Luis Paz‐Ares, Damian R. Page, et al.. (2018). P1.01-04 Treatment Patterns and Overall Survival Following Biomarker Testing in Real-World Advanced NSCLC Patients. Journal of Thoracic Oncology. 13(10). S459–S460. 1 indexed citations

Curtis, Melissa D., Sandra D. Griffith, Melisa Tucker, et al.. (2018). Development and Validation of a High‐Quality Composite Real‐World Mortality Endpoint. Health Services Research. 53(6). 4460–4476. 166 indexed citations

Shewade, Ashwini, Peter Lambert, Brandon Arnieri, et al.. (2017). Characteristics of advanced non-small cell lung cancer (aNSCLC) patients (pts) receiving molecular diagnostic (MD) testing in U.S. routine clinical practice.. Journal of Clinical Oncology. 35(15_suppl). e20627–e20627. 1 indexed citations

Luhn, Patricia, Deborah Kuk, Gillis Carrigan, et al.. (2017). Validation of diagnosis codes to identify side of colon in an electronic health record registry.. Journal of Clinical Oncology. 35(4_suppl). 568–568. 2 indexed citations

Arnieri, Brandon, Coen Bernaards, Kenneth Wilhelm, et al.. (2016). Changing Demographics and Treatment Patterns in Patients the United States with Chronic Lymphocytic Leukemia in the First-Line Setting As Assessed Using a Novel Electronic Health Record Database. Blood. 128(22). 4787–4787. 3 indexed citations

10.

Goldman, J M, Joleen M. Hubbard, Jaume Capdevila, et al.. (2014). 382 Phase Ib study of oral dual-PI3K/mTOR inhibitor GDC-0980 in combination with capecitabine and mFOLFOX6 + bevacizumab in patients with advanced solid tumors and colorectal cancer. European Journal of Cancer. 50. 122–123. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact